Zynyz

Active Ingredient(s): Retifanlimab-dlwr
FDA Approved: * March 22, 2023
Pharm Company: * INCYTE CORP
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Zynyz 25 mg/ml Intravenous Injection
NDC: 50881-006
Labeler:
Incyte Corporation